Multicenter Ventral Mesh Rectopexy Registry Collaborative

Launched by UNIVERSITY HOSPITAL, ANTWERP · Jun 15, 2023

Keywords

ClinConnect Summary

The Multicenter Ventral Mesh Rectopexy Registry Collaborative is a clinical trial that aims to gather information about patients with pelvic organ prolapse who are undergoing a specific type of surgery called ventral mesh rectopexy. This surgery is performed using advanced techniques like laparoscopy or robotic surgery. The trial will look at how well the surgery works over time, including any complications that may arise, such as issues with the mesh used in the procedure or the need for additional surgeries. Researchers will focus on questions like whether this surgery is the best option for treating certain conditions related to pelvic organ prolapse and how factors like pelvic descent might affect the outcomes.

To participate in this study, individuals must be at least 18 years old and have been diagnosed with a type of pelvic organ prolapse that requires this surgery. Eligible patients should be able to provide written consent and communicate via email to complete follow-up questionnaires. This study is currently recruiting participants of any gender, and those interested can expect regular check-ins to assess their recovery and any complications post-surgery. The information gathered will help improve treatment options for future patients facing similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of posterior pelvic organ prolaps planned for laparoscopie or robotic ventral mesh rectopexy with or without concomittant surgery.
• • All patients 18 years or older and are able to complete a written informed conscent are eligble for inclusion.
• Exclusion Criteria:
• • 1. Inability to complete a written informed conscent
• • 2. Pregnant women
• • 3. No email adress available to send the questionnaires to
• • 4. Language barrier or impossiblity to fill in the questionnaires (at the discretion oft he treating physician)